Browse the evidence

The rate of hospitalisations for stable angina pectoris (SAP) was lower by two-thirds after bariatric surgery in obese adults.

Bariatric surgery may significantly reduce hospitalisation rates for SAP in obese patients.

A-mode ultrasound (US) can provide a similar degree of accuracy for tracking group-based fat loss in women compared to air displacement plethysmography (ADP).

Researchers and practitioners can consider US as a viable option for monitoring group-based changes in body fat over time.

Progressive long-term aerobic exercise significantly influenced EPOC in overweight/obese men but not women.

Men may experience greater benefits in EPOC from long-term aerobic exercise compared to women.

EPOC contributed modestly to energy expenditure compared to the exercise itself.

While EPOC is a factor in energy expenditure, the primary energy burn comes from the exercise itself.

Change in EPOC was correlated with change in energy expenditure at 9 months and 16 months for men.

For men, improvements in EPOC may be linked to increases in overall energy expenditure.

The effectiveness of technology-based WLMIs varies.

Practitioners should be aware that results from technology-based interventions may differ significantly.

There is no one-size-fits-all approach to dietary recommendations for the management and treatment of chronic diseases such as obesity.

Practitioners should consider individualized dietary recommendations rather than a standard approach.

There were no statistical differences in SMM and total strength improvements between the narrow and wide repetition zones.

Both repetition zones are equally effective for muscle and strength gains in older women.

Continuous positive airway pressure (CPAP) is the best treatment option for obstructive sleep apnea (OSA).

Practitioners should prioritize CPAP as the primary treatment for patients diagnosed with OSA.

Telemedicine may improve compliance with CPAP treatment for obstructive sleep apnea.

Incorporating telemedicine strategies may help practitioners improve patient adherence to CPAP therapy.

The proportion of individuals at risk of deficiency increased significantly in the Atkins, LEARN, and Ornish groups for various micronutrients.

Practitioners should monitor micronutrient intake in patients following these diets to prevent deficiencies.

For the Zone group, the risk of deficiencies significantly decreased for vitamins A, C, E, and K.

Dietitians may consider the Zone diet as a better option for maintaining vitamin adequacy.

The Diet Satisfaction Score consists of 10 items measuring one dimension with a Cronbach's alpha of 0.85.

Clinicians can use the Diet Satisfaction Score to assess diet satisfaction reliably.

Test-retest reliability of the Diet Satisfaction Score was good with an intraclass correlation coefficient of 0.64.

The Diet Satisfaction Score can be reliably used over time in clinical settings.

Each 1-point increase in Diet Satisfaction Score was associated with longer diet duration by 1.7 weeks.

Higher diet satisfaction may lead to longer adherence to dietary changes.

34.9% of coronary heart disease (CHD) patients were obese at hospitalization.

Practitioners should be aware that a significant proportion of CHD patients are obese.

19.5% of obese patients lost ≥5% of weight by the time of the study visit.

Weight loss interventions may be effective for a minority of obese CHD patients.

Blood flow increased significantly after both arm and leg exercises.

Increased blood flow after exercise can enhance nutrient delivery to muscles.

Measured energy expenditure was approximately 200 kcal/day higher than reported metabolizable energy intake.

Practitioners should be aware that self-reported dietary intake may underestimate actual energy needs.

Dietitians had the lowest difference between intake and expenditure, with no large discrepancies.

Dietitians may provide more accurate dietary intake reports, which could inform dietary assessments.

There were early signs of weight regain in both intervention groups after 12 months.

Practitioners should be aware of the potential for weight regain after the intervention period.

There is no single mode of physical activity that is superior for weight loss or prevention of weight gain.

Advise clients that various forms of physical activity can be effective for weight management, and they should choose what they enjoy.

Factors linked to greater weight loss on liraglutide include being female, not having diabetes, having relatively high baseline weight, and losing at least 4% of initial weight after 16 weeks of treatment.

Healthcare providers should consider these factors when predicting weight loss outcomes for patients on liraglutide.

Baseline body mass index, race, and age seem less relevant for predicting weight-loss response to liraglutide.

Providers may deprioritize these factors when assessing weight loss potential with liraglutide.